SOLY News and Press, Soliton Inc. From 07/15/20

HOUSTON , July 15, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology, today announced that its 510(k) application for premarket clearance filed with the U.S. Food and Dr...

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...

HOUSTON , July 9, 2020 /PRNewswire/ -- Soliton, Inc. (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology, today announced that Company CEO Chris Capelli has been invited to present at the Re-Engaging M...

HOUSTON , July 1, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology, today announced that it filed for 510(k) premarket clearance with the U.S. Food and Drug Administrat...

Gainers:  MDC Partners (NASDAQ: MDCA )  +95% . More news on: MDC Partners Inc., Vaxart, Inc., iBio, Inc., Stocks on the move, , Read more ...

HOUSTON , June 26, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today announced the pricing of its underwritten public offering of 4,216,868 shares of common stock at a public of...

HOUSTON , June 25, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today announced that it intends to offer shares of its common stock in an underwritten public offering. In additio...

HOUSTON , June 15, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today announced that new positive data from the company's pivotal cellulite clinical trial was presented in a...

HOUSTON , June 9, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, will present the results from its pivotal cellulite trial through a virtual video presentation at the American Acad...

HOUSTON, Texas , May 18, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today announced that the results from its pivotal cellulite trial have been accepted for virtual video prese...